STX-478

STX-478 (compound 80) is an oral CNS-penetrant allosteric mutant-selective PI3Kα inhibitor. STX-478 shows robust and durable tumor regression and can be used in cancer research.


Cat. No.: EX-A7997	Purity: >98%

	Chemical structure of STX-478

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
10mg	625	In-stock
25mg	925	In-stock
50mg	1625	In-stock
100mg	get quote	get quote
250mg	get quote	In-stock
1g	get quote	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


CAS No.	2883540-92-7
Purity	>98%
Formula	C16H12F5N5O2
Mol Weight	401.2908
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1.
CoA	CoA of STX-478


		Search